Anaemia and heart failure

Heart

Volumn 90, Issue 9, 2004, Pages 977-979

  Coats, A J S ^a  

^a University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; IRON; OXYGEN;

ANEMIA; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; HEART FAILURE; HEMOGLOBIN DETERMINATION; HUMAN; MORTALITY; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

ANEMIA; CARDIAC OUTPUT, LOW; CHRONIC DISEASE; ERYTHROPOIETIN; HUMANS;

EID: 4344717835     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.012997     Document Type: Review

References (26)

1. Franciosa JA, Baker BJ, Seth L. Pulmonary versus systemic hemodynamics in determining exercise capacity of patients with chronic left ventricular failure. Am Heart J 1985;110:807-13.
2. Clark AL, Poole-Wilson PA, Coats AJ. Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol 1996;28:1092-102.
3. Anker SD, Sharma R. The syndrome of cardiac cachexia. Int J Cardiol 2002;85:51-66.
4. Brink M, Anwar A, Delafantaine P. Neurohormonal factors in the development of catabolic/anabolic imbalance and cachexia. Int J Cardiol 2002;85:111-21.
5. Conraads VM, Bosmans JM, Vrints CJ. Chronic heart failure: an example of a systemic chronic inflammatory disease resulting in cachexia. Int J Cardiol 2002;85:33-49.
6. Clausen JP. Circulatory adjustments to dynamic exercise and effect of physical training in normal subjects and in patients with coronary artery disease. Progress in Cardiovascular Diseases 1976;18:459-95.
7. Tanabe Y, Nakagawa I, Ito E, et al. Hemodynamic basis of the reduced oxygen uptake relative to work rate during incremental exercise in patients with chronic heart failure. Int J Cardiol 2002;83:57-62.
8. Kalra PR, Bolger AP, Sharma R, et al. The relationship between hemoglobin and exercise capacity in patients with stable chronic heart failure (CHF). Circulation 2002;106(suppl):II-570.
9. Silverberg DS, Wexler D, Blum M, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 2000;35:1737-44.
10. Wisniacki N. Is anaemia a cause or a consequence of heart failure in the elderly? [abstract] Heart 2001;85(suppl I):P4.
11. Tanner H, Moschovitis G, Kuster GM, et al. The prevalence of anemia in chronic heart failure. Int J Cardiol 2002;86:115-21.
12. Cromie N, Lee C, Struthers AD. Anaemia in chronic heart failure: what is its frequency in the UK and its underlying causes? Heart 2002;87:377-8.
13. Chatterjee B, Nydegger UE, Mohacsi P. Serum erythropoietin in heart failure patients treated with ACE-inhibitors or AT(1) antagonists. Eur J Heart Fail 2000;2:393-8.
14. Iversen PO, Woldbaek PR, Tonnessen T, et al. Decreased hematopoiesis in bone marrow of mice with congestive heart failure. Am J Physiol Regul Integr Comp Physiol 2002;282:R166-72.
15. Bolger AP, Doehner W, Sharma R, et al. Anaemia in chronic heart failure: the relationship to inflammatory cytokine expression and prognostic importance. Circulation 2002;106(suppl):570-1.
16. Volpe M, Tritto C, Testa U, et al. Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles. Am J Cardiol 1994;74:468-73.
17. Jensen J, Eiskjaer H, Bagger JP, et al. Elevated level of erythropoietin in congestive heart failure: relationship to renal perfusion and plasma renin. J Intern Med 1993;233:125-30.
18. McClellan WM, Flanders WD, Langston RD, et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol 2002;13:1928-36.
19. Horwich TB, Fonarow GC, Hamilton MA, et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39:1780-6.
20. Al-Ahmad A, Rand WM, Manjunath G, et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001;38:955-62.
21. Anker SD, Sharma R, Francis D, et al. Anemia and survival in 3044 patients with chronic heart failure (CHF) in the ELITE II trial. Circulation 2002;106(suppl):472.
22. Herzog CA, Li S, Collins AJ. The impact of congestive heart failure (CHF), chronic kidney disease (CKD), and anemia on survival in the Medicare population. Circulation 2002;106(suppl):471-2.
23. Silverberg DS, Wexler D, Sheps D, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 2001;37:1775-80.
24. Besarab A, Bolton WK, Browne JK, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998;339:584-90.
25. Harrington D, Chua TP, Coats AJ. The effect of salbutamol on skeletal muscle in chronic heart failure. Int J Cardiol 2000;73:257-65.
26. Coats AJ. Making choices in cardiology: difficulties of rationing and equality of access. Int J Cardiol 2001;78:209-12.